Phase I Oncology Archive

A building with a stone facade displays a sign that reads
A Phase 1 multicenter, open-label, study to evaluate the safety and pharmacokinetics of SHY-ONC6 in patients with advanced or metastatic solid tumors who have progressed on or are intolerant to standard therapies
A building with a stone facade displays a sign that reads
Frederic Zenhausern, Ph.D., MBA, FNAI, FAIMBE
A building with a stone facade displays a sign that reads
Ha Seung, DNP, FNP-C, AOCNP
A building with a stone facade displays a sign that reads
Sunil Sharma, M.D., MBA, FACP
A building with a stone facade displays a sign that reads
Nicholas J. Schork, PhD
A building with a stone facade displays a sign that reads
Sarah Danielle LeGrand, M.S.N., A.G.A.C.N.P.-B.C.
A building with a stone facade displays a sign that reads
Courtney E. Mellen, MSN-Ed, AGNP-C, OCN
A building with a stone facade displays a sign that reads
Joseph Mikhael, M.D., M.Ed., F.R.C.P.C., F.A.C.P., F.A.S.C.O.
A building with a stone facade displays a sign that reads
Erin Pierce, M.S.N., A.P.R.N., F.N.P-C
A building with a stone facade displays a sign that reads
Justin Moser, M.D.